Table 1.
Clinical features of patients with upper tract urothelial carcinoma.
| Clinical features | Median (range)/no. (%) (N = 245) |
|---|---|
| Gender (male/female) | 132/113 |
| Age,a y | 69 (31-88) |
| BMIa (n = 179), kg/m2 | 24.3 (15.6-34.0) |
| ASA score (n = 216), % | |
| 1 | 32 (14.8) |
| 2 | 146 (67.6) |
| 3 | 38 (17.6) |
| Surgery year, % | |
| 2002-2010 | 69 (28.2) |
| 2011-2016 | 176 (71.8) |
| Gross hematuria, % | 182 (74.3) |
| Concomitant bladder cancer, % | 28 (11.4) |
| History of bladder cancer, % | 10 (4.1) |
| Smoking history (n = 240), % | 29 (12.1) |
| eGFR (n = 243), mL/min/1.73 m2 | |
| ⩾90 | 20 (8.2) |
| 60-90 | 104 (42.4) |
| 30-60 | 96 (39.2) |
| <30 | 23 (9.4) |
| Side (left/right) | 109/136 |
| Location, % | |
| Renal pelvis | 109 (44.5) |
| Ureter | 121 (49.4) |
| Both | 15 (6.1) |
| Tumor sizea (n = 223), cm | 3.0 (0.5-11.0) |
| Hydronephrosis (n = 230), % | 132 (57.4) |
| Multifocality, % | 42 (17.1) |
| Sessile, % | 44 (18.0) |
| pT, % | |
| Ta | 31 (12.7) |
| 1 | 52 (21.2) |
| 2 | 78 (31.8) |
| 3 | 78 (31.8) |
| 4 | 6 (2.4) |
| pN+, % | 7 (2.9) |
| Urine cytology positive (n = 88), % | 27 (30.7) |
| Biopsy high-grade (n = 141), % | 48 (34.0) |
| Postop pathologic high grade, % | 178 (72.7) |
Abbreviations: ASA, American Society of Anesthesiologists; BMI, body mass index; eGFR, estimated glomerular filtration rate.
a
Continuous variables were presented in median (range).